Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02587403 · ClinicalTrials.gov registry record · NA
A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair
A NA study of Ventral Hernia, sponsored by RTI Surgical.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT02587403: Completed NA study of Ventral Hernia, sponsored by RTI Surgical.
NCT02587403 is a NA study of Ventral Hernia that has completed, run by RTI Surgical. The registered enrollment target is 120 participants, below the 136-participant average among 18 other Ventral Hernia trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02587403, a NA study of Ventral Hernia, has completed, sponsored by RTI Surgical.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to compare the effectiveness of Fortiva Porcine Dermis versus Strattice Reconstructive Tissue Matrix for the underlay reinforcement of complex ventral hernia repair and assess post-operative complication rates, long term hernia recurrence rates.
Primary Outcome
True hernia recurrence as diagnosed by physical exam or CT scan
Conditions Studied
Interventions
- DEVICE Fortiva™ Porcine Dermis
- DEVICE Strattice™ Reconstructive Tissue Matrix
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2015-12-02 |
| Est. Completion | 2023-09-19 |
| Phase | NA |
What the finished NCT02587403 record still lists
NCT02587403 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 136-participant average among 18 other Ventral Hernia trials with a reported enrollment target (12% lower).
The record links to 1 condition, with Ventral Hernia appearing as the primary indexed condition, and to 2 interventions - of which Fortiva™ Porcine Dermis is the first listed.
NCT02587403 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT02587403 about?
NCT02587403 is a clinical study titled "A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair". The objective of this study is to compare the effectiveness of Fortiva Porcine Dermis versus Strattice Reconstructive Tissue Matrix for the underlay reinforcement of complex ventral hernia repair and assess post-operative complication rates, long term hernia recurrence rates.
What is the current status of trial NCT02587403?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2015-12-02. Estimated completion is 2023-09-19.
What conditions does trial NCT02587403 study?
This clinical trial studies the following conditions: Ventral Hernia.
What interventions are being tested in trial NCT02587403?
The interventions under investigation include: Fortiva™ Porcine Dermis (DEVICE), Strattice™ Reconstructive Tissue Matrix (DEVICE).
Who is sponsoring clinical trial NCT02587403?
This trial is sponsored by RTI Surgical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02587403 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventral Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02587403's enrollment target sits among peer trials
120 10th of 18 higher than 9 of 18 other Ventral Hernia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventral Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
RECRUITING · NA
-
Robotic Versus Open Ventral Hernia Repair
RECRUITING · NA
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Hernia Surgery (Enable Hernia Repair)
ACTIVE NOT RECRUITING · NA
-
Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair
ACTIVE NOT RECRUITING · NA
-
CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI